SavedAdd your journal

Journals / Acta Medica Alanya / 2018 / Cilt: 2 Sayı: 3

A Case of Parathyroid Carcinoma with Presented Lung Metastases

Akciğer Metastazları ile Görülen Paratiroid Karsinomu Olgusu

Hasret Cengiz0000-0002-5216-3368
Süleyman Baş(Sağlık Bilimleri Üniversitesi Haydarpaşa Numune Hastanesi İç Hastalıkları Kliniği)0000-0002-5883-445X
Yasemin Tütüncü0000-0001-6975-7501
Pages
206–209
Publication Date
2018-11-13
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our case is an exciting and rare case due to first presentation is hypercalcemia and hyperparathyroidia with lung methastazes without detectable parathyroid mass in neck.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Parathyroid carcinoma is one of the rarest endocrinologic tumors.
📊
Key Findings & Data:It covers on average %1 of all hyperparathyroid cases.
💡
Conclusion & Impact:Our case is an exciting and rare case due to first presentation is hypercalcemia and hyperparathyroidia with lung methastazes without detectable parathyroid mass in neck.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Paratiroid Karsinomu · Akciğer metastazı · Olgu sunumu

Abstract

Parathyroid carcinoma is one of the rarest endocrinologic tumors. It covers on average %1 of all hyperparathyroid cases. It can be seen as a part of genetic syndromes or generally as sporadic cases. Man/Woman ratio is 0,8/1 . 90% of parathyroid carcinoma is usually hormonally active and presents with hypercalcemia clinic, and in many cases also a palpable or detectable big neck mass is present. Our case is an exciting and rare case due to first presentation is hypercalcemia and hyperparathyroidia with lung methastazes without detectable parathyroid mass in neck.

Özet

Paratiroid karsinomu en nadir görülen endokrin tümörlerden biridir. Hiperparatiroidi vakalarının ortalama %1 ini oluşturur. Sporadik olarak görülebildiği gibi, genetik bir sendromun komponenti olarak da görülebilir. E/K oranı 0,8/1 dir. Paratiroid karsinomlarının %90’ı hormonal olarak aktiftir ve hiperkalsemi kliniği ile prezente olurlar. Ayrıca birçok vakada boyunda palpabl büyük bir kitle de bulunur. Bizim vakamız preoperatif görüntülemelerde primer tümör ile ilgili hiçbir iz bulunamamış; akciğer metastazları ile prezente olmuş nadir ve heyecan verici bir vakadır

🔖

Cite This Article

Cengiz, H., Baş, S., Tütüncü, Y. (2018). A Case of Parathyroid Carcinoma with Presented Lung Metastases. Acta Medica Alanya, Cilt: 2 Sayı: 3, 206–209. https://doi.org/10.30565/medalanya.403856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Wei CH, Harari A, et al. Parathyroid carcinoma:update and guidelines for management.Current Treat Options Oncol. 2012 Mar;13[1]:11-23.
  2. Vila Duckworth L. et al. İntrathyroidal parathyroid carcinoma:report an unusual case andr eview of literature. Case Rep. Pathol. 2013;2013:198643-48.
  3. Verges MP, Herges HI, Kleiner DE, et al.The role of prognostic markers [MIB-1,RB and bcl-2] in the diagnosis of parathyroid tumors.Modern Pathology.1997;10[1]:12-17.
  4. Vasef MA, Brynes RK, et al. Expression of cyclin D1 in parathyroid carcinomas,adenomas and hyperplasias:a parafin immunohistochemical study.modern Pathol. 1999;12[4]:412-16.
  5. Erickson LA, Jin L, Wollen P,T hompson GB. Paratihroid hyperplasia adenomas and carcınomas: a differential expression of P27[kip 1] protein.American Journal of Surgical Pathol.1999;23[3]:288-295.
  6. Tan M, Morrison C, Wang P, et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroidcarcinoma. ClinicalCancerResearch. 2004;10[19]:6629–6637.
  7. Owen RP,Silver CE, Pellitteri PK et al. Parathyroid Carcinoma:areview. Head and Neck 2011;33:429.
  8. Shaha AR, Ferlito A, et al. Distant methastasis from throid and parathyroid cancer.OrlJ.Otorhinolarangeal.Relatspec 2001 Jul-Aug;63[4]:243-9.
  9. Obara T, Okamoto T,et al. Functioning parathroid carcinoma, clinicopathologic features and rational treatment.Semin.surg Oncol 1997 Mar-April;13[2]:134-41.
  10. Yamamoto T, Matsumura A. Comment on ‘Clinicalreview 122:Parathyroid Carcınoma’. J Clin Endocrinol Metab 2001:86;5091.
  11. Hundley JC, Albertson FA, et al.Resection of pulmonary methastasis from parathroid carcinoma.Am Surg 2003 Sp;69[9]:779-83.
  12. Van Hooven ER,Kievit J, et al. Successfull resection for hepatic and pulmonary methastazis in a patient with parathyoid carcınoma.Jpn J Clin. Oncol.1996 ap;26[2]:99-102.
  13. Obara J,Okamoto T, et al. Surgical and medical management of patients with pulmonary methastasis from parathroid carcınoma.Surgery 1993 Dec;114[6]:1040-8.
  14. Tochio M, Takali H, et al. A case report of 20 lung radiofrequencyablation sessions for 50 lung methastasis from parathroidcarcinoma causing hyperparathroidism.Cardiovasc. İntervent Radiol.2010 Jun;33[3]:657-9.
  15. Kuhlencordt F, Lozano-Tonkin C, Kracht J, Bartelheimer H. Pulmonary nodüles as early sign of primary parathyroid carcinoma. Deutsch Med Wochenschr 1974 oct 4;99[40]:1957-60.
  16. Vasef MA, Brynes RK, et al. Expression of cyclin D1 in parathyroid carcinomas,adenomas and hyperplasias:a parafin immunohistochemical study.modern Pathol. 1999;12[4]:412-16.
  17. Owen RP,Silver CE, Pellitteri PK et al. Parathyroid Carcinoma:areview. Head and Neck 2011;33:429.
  18. Obara T, Okamoto T,et al. Functioning parathroid carcinoma, clinicopathologic features and rational treatment.Semin.surg Oncol 1997 Mar-April;13[2]:134-41.
  19. Hundley JC, Albertson FA, et al.Resection of pulmonary methastasis from parathroid carcinoma.Am Surg 2003 Sp;69[9]:779-83.
  20. Van Hooven ER,Kievit J, et al. Successfull resection for hepatic and pulmonary methastazis in a patient with parathyoid carcınoma.Jpn J Clin. Oncol.1996 ap;26[2]:99-102.